[Trial of Oropivalone-bacitracin in the local treatment of pharyngitis following the radiotherapy of cancers of the upper respiratory and digestive tract].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001414:Bacitracin / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004067:Digestive System Neoplasms / Q000532:radiotherapy*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008297:Male; D010612:Pharyngitis / Q000188:drug therapy* / Q000209:etiology; D011832:Radiation Injuries / Q000188:drug therapy*; D012142:Respiratory Tract Neoplasms / Q000532:radiotherapy*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D001414:Bacitracin; C019112:tixocortol pivalate; D006854:Hydrocortisone
Essai d'Oropivalone bacitracine dans le traitement local des pharyngites consécutives à la radiothérapie des cancers des V.A.D.S.